MPM BioImpact’s Deciphera Pharmaceuticals DCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-215,570
Closed -$13.4M – 12
2019
Q4
$13.4M Buy
+215,570
New +$10.2M 4.75% 7

Other funds holding DCPH

MPM BioImpact's DCPH Position: Q1 2020 in Review

MPM BioImpact sold out of Deciphera Pharmaceuticals (DCPH) in Q1 2020, closing a stake of 215,570 shares — an estimated $13.4M sold.

MPM BioImpact first reported a position in DCPH in Q4 2019 and held it in 1 quarter. The position peaked at $13.4M in Q4 2019. 148 funds tracked by Wall St. Rank hold DCPH as of Q1 2020.

  • MPM BioImpact reported no remaining Deciphera Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • MPM BioImpact sold 215,570 Deciphera Pharmaceuticals shares in Q1 2020, an estimated $13.4M.
  • MPM BioImpact first reported a position in Deciphera Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • MPM BioImpact's Deciphera Pharmaceuticals position peaked at $13.4M in Q4 2019.
  • 148 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals as of Q1 2020.

Based on MPM BioImpact's 13F filing for Q1 2020, filed 13 May 2020.